Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results
Stocks in this Quantisnow insightHealth Care
Historical context for CYRX
Across the 6 sessions after earlier CYRX headlines, the stock closed higher 1 times and lower 5 times, with a median move of 2.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CYRX | SPY |
|---|---|---|---|
| Feb 17, 2026 | Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 | +1.4% | +0.2% |
| Feb 11, 2026 | Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series | -2.3% | -0.0% |
| Nov 6, 2025 | Cryoport Systems Wins 2025 BioTech Breakthrough Award For "BioServices Innovation of the Year" | -2.3% | -1.1% |
| Nov 5, 2025 | Cryoport Reports Third Quarter 2025 Financial Results | -7.5% | +0.3% |
| Oct 30, 2025 | Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain | -2.6% | -1.1% |
| Oct 21, 2025 | Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025 | -3.7% | -0.0% |
Quantisnow market dataNASDAQ
CYRX
CryoPort Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for CYRX
Full CYRX profile on Quantisnow Follow CYRX and get a push notification the moment its next story breaks.